Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin in 2nd/3rd Line NSCLC
NCT00105092Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enzastaurin in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started Mar 2005; status: completed.
02
Drugs
enzastaurin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00105092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105092.